Filing Details

Accession Number:
Form Type:
Zero Holdings:
Publication Time:
2016-06-27 16:26:24
Reporting Period:
Filing Date:
Accepted Time:
2016-06-27 16:26:24
SEC Url:
Form 4 Filing
Cik Name Symbol Sector (SIC) IRS No
1178711 Paratek Pharmaceuticals Inc. PRTK Pharmaceutical Preparations (2834) 330960223
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1216917 Michael Bigham C/o Paratek Pharmaceuticals, Inc.
75 Park Plaza, 4Th Floor
Boston MA 02116
Chairman And Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2016-06-23 20,000 $13.45 100,000 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
  1. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $13.27 to $13.50, inclusive. The reporting person undertakes to provide to Paratek Pharmaceuticals, Inc., any security holder of Paratek Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote (1) to this Form 4.